Goldberg John Mayer 4
4 · Oncorus, Inc. · Filed Mar 3, 2021
Insider Transaction Report
Form 4
Oncorus, Inc.ONCR
Goldberg John Mayer
SVP, Clinical Development
Transactions
- Award
Employee Stock Option (right to buy)
2021-03-01+61,063→ 61,063 totalExercise: $15.85Exp: 2031-02-28→ Common Stock (61,063 underlying)
Footnotes (1)
- [F1]Twenty-five percent (25%) of the shares subject to the option shall vest on March 1, 2022, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.